Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren’s syndrome

G. M. Verstappen; L. De Wolff; S. Arends; H. M. Heiermann; Y. Van Sleen; A. Visser; J. H. Terpstra; D. Diavatopoulos; M. Van der Heiden; A. Vissink; D. Van Baarle; F. G. M. Kroese; H. Bootsma

doi:10.1136/annrheumdis-2022-eular.1598

Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren’s syndrome

G. M. Verstappen, L. De Wolff, S. Arends, H. M. Heiermann, Y. Van Sleen, A. Visser, J. H. Terpstra, D. Diavatopoulos, M. Van der Heiden, A. Vissink, D. Van Baarle, F. G. M. Kroese, H. Bootsma

Onderzoeksoutput › Academic

Originele taal-2	English
Pagina's (van-tot)	652-653
Aantal pagina's	2
Tijdschrift	Annals of the Rheumatic Diseases
Volume	81
DOI's	https://doi.org/10.1136/annrheumdis-2022-eular.1598
Status	Published - jun.-2022

Toegang tot document

10.1136/annrheumdis-2022-eular.1598

Handle.net

Permanente koppeling

Citeer dit

Verstappen, G. M., De Wolff, L., Arends, S., Heiermann, H. M., Van Sleen, Y., Visser, A., Terpstra, J. H., Diavatopoulos, D., Van der Heiden, M., Vissink, A., Van Baarle, D., Kroese, F. G. M., & Bootsma, H. (2022). Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren’s syndrome. Annals of the Rheumatic Diseases, 81, 652-653. https://doi.org/10.1136/annrheumdis-2022-eular.1598

@article{e74e99d2c900426e99b0c1a6ea5e7386,

title = "Immunogenicity and safety of COVID-19 vaccination in patients with primary Sj{\"o}gren{\textquoteright}s syndrome",

author = "Verstappen, {G. M.} and {De Wolff}, L. and S. Arends and Heiermann, {H. M.} and {Van Sleen}, Y. and A. Visser and Terpstra, {J. H.} and D. Diavatopoulos and {Van der Heiden}, M. and A. Vissink and {Van Baarle}, D. and Kroese, {F. G. M.} and H. Bootsma",

year = "2022",

month = jun,

doi = "10.1136/annrheumdis-2022-eular.1598",

language = "English",

volume = "81",

pages = "652--653",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ PUBLISHING GROUP",

}

Verstappen, GM , De Wolff, L , Arends, S , Heiermann, HM , Van Sleen, Y , Visser, A , Terpstra, JH, Diavatopoulos, D, Van der Heiden, M , Vissink, A , Van Baarle, D , Kroese, FGM & Bootsma, H 2022, 'Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren’s syndrome', Annals of the Rheumatic Diseases, vol. 81, blz. 652-653. https://doi.org/10.1136/annrheumdis-2022-eular.1598

TY - JOUR

T1 - Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren’s syndrome

AU - Verstappen, G. M.

AU - De Wolff, L.

AU - Arends, S.

AU - Heiermann, H. M.

AU - Van Sleen, Y.

AU - Visser, A.

AU - Terpstra, J. H.

AU - Diavatopoulos, D.

AU - Van der Heiden, M.

AU - Vissink, A.

AU - Van Baarle, D.

AU - Kroese, F. G. M.

AU - Bootsma, H.

PY - 2022/6

Y1 - 2022/6

U2 - 10.1136/annrheumdis-2022-eular.1598

DO - 10.1136/annrheumdis-2022-eular.1598

M3 - Meeting Abstract

VL - 81

SP - 652

EP - 653

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

ER -